Risks and benefits of testosterone therapy in older men
Authors:
- Grace HuangGHGrace Huang
- Shehzad BasariaSBShehzad Basaria
- Thomas G. TravisonTTThomas G. Travison
- Shalender BhasinSBShalender Bhasin
- 16 April 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 9 (7) , 414-424
Abstract
In young men (defined as age65 years) with androgen deficiency. Therefore, a general policy of testosterone replacement in all older men with age-related decline in testosterone levels is not justified.Keywords
This publication has 192 references indexed in Scilit:
- Low plasma testosterone and elevated carotid intima-media thickness: Importance of low-grade inflammation in elderly menAtherosclerosis, 2012
- Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24–45 years. The Cardiovascular Risk in Young Finns StudyAtherosclerosis, 2012
- Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: Potential role of follistatin in mediating testosterone actionMolecular and Cellular Endocrinology, 2012
- Clinical Meaningfulness of the Changes in Muscle Performance and Physical Function Associated With Testosterone Administration in Older Men With Mobility LimitationThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Adverse Events Associated with Testosterone AdministrationNew England Journal of Medicine, 2010
- Effects of Transdermal Testosterone on Bone and Muscle in Older Men with Low Bioavailable Testosterone Levels, Low Bone Mass, and Physical FrailtyJournal of the American Geriatrics Society, 2010
- Sex Hormone-Binding Globulin as an Independent Predictor of Incident Type 2 Diabetes Mellitus in MenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Low Testosterone Levels and the Risk of Anemia in Older Men and WomenArchives of internal medicine (1960), 2006
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingNature Clinical Practice Endocrinology & Metabolism, 2006